MCA’s purpose is to help people discover the therapeutic potential of cannabinoids and we are meticulous in our selection of affordable, high quality cannabinoid medicines. Our products are supplied to eligible patients and we also source products for industry partners who value our passion, deep experience and culture of care.
Clinical research is critical to the future of the industry and the development of pharmaceutical cannabinoid medicine. MCA’s R&D program is already underway, focusing on medicines that may help people and animals have a better quality of life.
Our long-term goal is to manufacture cost-effective, superior quality, cannabinoid medicine for distribution across Australia and around the world. We are committed to the most up-to-date manufacturing techniques that will be housed within our GMP facility.
MCA has approval to develop a state-of-the-art cultivation facility in regional NSW. Our best-practice GACP & GMP cultivation methods will produce high quality eco-friendly cannabis products. Off-grid renewable resources will help minimise environmental impact.